Scott Marek is assistant professor of radiology in the Mallinckrodt Institute of Radiology at Washington University School of Medicine in St. Louis. Marek received a Ph.D. in neuroscience from the University of Pittsburgh, where he gained expertise in pediatric neuroimaging with Beatriz Luna. Subsequently, he completed a postdoctoral fellowship with Nico Dosenbach at Washington University School of Medicine, where he gained expertise in functional mapping of individual brains and leveraging big data to quantify the reproducibility of brain-wide association studies. He now runs his own lab focused on precision imaging and deep phenotyping of adolescent twins with depression, as well as population neuroscience approaches using large datasets, such as the Adolescent Brain Cognitive Development (ABCD) Study.
Scott Marek
Assistant professor of radiology
Washington University School of Medicine in St. Louis
From this contributor
Breaking down the winner’s curse: Lessons from brain-wide association studies
We found an issue with a specific type of brain imaging study and tried to share it with the field. Then the backlash began.
Breaking down the winner’s curse: Lessons from brain-wide association studies
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.